ISIN | LU2207278404 |
---|---|
Valor Number | 120730677 |
Bloomberg Global ID | |
Fund Name | Kieger Impact Healthcare Fund Class A CHF (H) Accumulating |
Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fund Provider | Kieger AG |
Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related companies or issuers worldwide (including Emerging Markets) with a focus on issuers that contribute to the realisation of the healthcare related United Nations Sustainable Development Goals ("SDGs"). No guarantee can be given that the investment objective will be achieved. |
Peculiarities |
Current Price * | 75.89 CHF | 10.09.2025 |
---|---|---|
Previous Price * | 77.13 CHF | 09.09.2025 |
52 Week High * | 89.58 CHF | 19.09.2024 |
52 Week Low * | 72.46 CHF | 07.08.2025 |
NAV * | 75.89 CHF | 10.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 50,168,785 | |
Unit/Share Assets *** | 6,075,113 | |
Trading Information SIX |
YTD Performance | -5.24% |
31.12.2024 - 10.09.2025
31.12.2024 10.09.2025 |
---|---|---|
1 month | +3.93% |
11.08.2025 - 10.09.2025
11.08.2025 10.09.2025 |
3 months | -8.50% |
10.06.2025 - 10.09.2025
10.06.2025 10.09.2025 |
6 months | -7.24% |
10.03.2025 - 10.09.2025
10.03.2025 10.09.2025 |
1 year | -12.07% |
10.09.2024 - 10.09.2025
10.09.2024 10.09.2025 |
2 years | -17.67% |
11.09.2023 - 10.09.2025
11.09.2023 10.09.2025 |
3 years | -28.80% |
12.09.2022 - 10.09.2025
12.09.2022 10.09.2025 |
5 years | -24.11% |
31.08.2022 - 10.09.2025
31.08.2022 10.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk AS Class B | 3.51% | |
---|---|---|
Natera Inc | 3.50% | |
Humana Inc | 3.50% | |
DexCom Inc | 3.49% | |
Exact Sciences Corp | 3.47% | |
Sandoz Group AG Registered Shares | 3.46% | |
Hypera SA | 3.46% | |
RadNet Inc | 3.45% | |
Hologic Inc | 3.44% | |
Sanofi SA | 3.44% | |
Last data update | 30.06.2025 |
TER *** | 1.27% |
---|---|
TER date *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.27% |
SRRI ***
|
|
SRRI date *** | 30.09.2022 |